Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors.
Khan, Tahsin M
Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors. [electronic resource] - Pancreas 08 2016 - 1032-5 p. digital
Publication Type: Journal Article
1536-4828
10.1097/MPA.0000000000000572 doi
Biomarkers, Tumor--blood
Chromogranin A--blood
Female
Humans
Intestinal Neoplasms--blood
Intestine, Small--pathology
Liver Neoplasms--blood
Male
Middle Aged
Neuroendocrine Tumors--blood
Prognosis
Radioimmunoassay--methods
Retrospective Studies
Sensitivity and Specificity
Elevated Serum Pancreastatin Is an Indicator of Hepatic Metastasis in Patients With Small Bowel Neuroendocrine Tumors. [electronic resource] - Pancreas 08 2016 - 1032-5 p. digital
Publication Type: Journal Article
1536-4828
10.1097/MPA.0000000000000572 doi
Biomarkers, Tumor--blood
Chromogranin A--blood
Female
Humans
Intestinal Neoplasms--blood
Intestine, Small--pathology
Liver Neoplasms--blood
Male
Middle Aged
Neuroendocrine Tumors--blood
Prognosis
Radioimmunoassay--methods
Retrospective Studies
Sensitivity and Specificity